Company Filing History:
Years Active: 2008-2012
Title: Innovative Contributions of Hiroki Terauchi
Introduction
Hiroki Terauchi, an accomplished inventor based in Tsukuba, Japan, has made significant contributions to the field of pharmaceuticals. With two patents to his name, Terauchi focuses on the development of novel chemical compounds that address acid-related diseases. His work illustrates a dedication to advancing therapeutic solutions that enhance patient safety and efficacy.
Latest Patents
Terauchi's latest patent centers around a benzimidazole compound designed to serve as a therapeutic or prophylactic agent for acid-related diseases. This innovative compound exhibits an excellent inhibitory effect against gastric acid secretion and effectively maintains a high intragastric pH for extended periods. The compound demonstrates enhanced safety and appropriate physicochemical stability, with structural representations that include various alkyl groups and oxygenated functionalities. This advancement represents a significant step forward in treating conditions associated with gastric acid secretion.
Career Highlights
Hiroki Terauchi is affiliated with Eisai R&D Management Co., Ltd., where he has utilized his expertise to support the company's groundbreaking research in pharmaceutical development. His work not only contributes to the company's portfolio but also aims to improve therapeutic options available to patients worldwide.
Collaborations
In his research endeavors, Terauchi collaborates closely with notable colleagues, including Shuhei Miyazawa and Masanobu Shinoda. These partnerships foster a collaborative environment that enriches the innovation process and enhances the potential for successful outcomes in drug development.
Conclusion
Hiroki Terauchi stands out as a notable inventor in the pharmaceutical sector, with his innovative contributions significantly advancing treatments for acid-related diseases. His commitment to safety and effective therapy design continues to inspire progress in the field, making him a key figure within Eisai R&D Management Co., Ltd. and the broader scientific community.